These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25707623)

  • 41. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
    Bocchi EA; Böhm M; Borer JS; Ford I; Komajda M; Swedberg K; Tavazzi L;
    Cardiology; 2015; 131(4):218-24. PubMed ID: 25968495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
    Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A;
    Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
    Franciosa JA; Massie BM; Lukas MA; Nelson JJ; Lottes S; Abraham WT; Fowler M; Gilbert EM; Greenberg B;
    Am Heart J; 2004 Oct; 148(4):718-26. PubMed ID: 15459606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.
    Shore S; Aggarwal V; Zolty R
    J Card Fail; 2012 Dec; 18(12):919-24. PubMed ID: 23207080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement of Ventricular-Arterial Coupling in Elderly Patients with Heart Failure After Beta Blocker Therapy: Results from the CIBIS-ELD Trial.
    Dekleva M; Lazic JS; Soldatovic I; Inkrot S; Arandjelovic A; Waagstein F; Gelbrich G; Cvijanovic D; Dungen HD
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):287-94. PubMed ID: 25963064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure?
    Rohrer CK; Page RL; Shakar SF; Lindenfeld J
    J Card Fail; 2011 Oct; 17(10):875-7. PubMed ID: 21962427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
    Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
    J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension.
    Taniguchi T; Ohtani T; Mizote I; Kanzaki M; Ichibori Y; Minamiguchi H; Asano Y; Sakata Y; Komuro I
    J Cardiol; 2013 Jun; 61(6):417-22. PubMed ID: 23548374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carvedilol reduces aldosterone release in systolic heart failure.
    Aggarwal A; Wong J; Campbell DJ
    Heart Lung Circ; 2006 Oct; 15(5):306-9. PubMed ID: 16935558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study.
    Tribouilloy C; Rusinaru D; Mahjoub H; Tartière JM; Kesri-Tartière L; Godard S; Peltier M
    Heart; 2008 Nov; 94(11):1450-5. PubMed ID: 18208832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.
    Domanski M; Krause-Steinrauf H; Deedwania P; Follmann D; Ghali JK; Gilbert E; Haffner S; Katz R; Lindenfeld J; Lowes BD; Martin W; McGrew F; Bristow MR;
    J Am Coll Cardiol; 2003 Sep; 42(5):914-22. PubMed ID: 12957443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of betablockers in elderly patients with congestive heart failure].
    Urrutia A; Lupón J; Altimir S; González B; Herreros J; Díez C; Coll R; Valle V; Rey-Joly C
    Med Clin (Barc); 2006 Feb; 126(6):206-10. PubMed ID: 16510092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
    Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M; Friberg L
    JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
    Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
    Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of Left Ventricular Ejection Fraction on the Effects of Supplemental Use of Angiotensin Receptor Blocker Olmesartan in Hypertensive Patients With Heart Failure.
    Miura M; Sakata Y; Miyata S; Shiba N; Takahashi J; Nochioka K; Takada T; Saga C; Shinozaki T; Sugi M; Nakagawa M; Sekiguchi N; Komaru T; Kato A; Fukuchi M; Nozaki E; Hiramoto T; Inoue K; Goto T; Ohe M; Tamaki K; Ibayashi S; Ishide N; Maruyama Y; Tsuji I; Shimokawa H;
    Circ J; 2016 Sep; 80(10):2155-64. PubMed ID: 27628221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of clinical outcomes in patients given carvedilol for heart failure.
    Greenberg B; Lottes SR; Nelson JJ; Lukas MA; Fowler MB; Massie BM; Abraham WT; Gilbert EM; Franciosa JA;
    Am J Cardiol; 2006 Dec; 98(11):1480-4. PubMed ID: 17126654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta-blockers and heart failure.
    Cruickshank JM
    Indian Heart J; 2010; 62(2):101-10. PubMed ID: 21180298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.
    Podbregar M; Voga G
    J Card Fail; 2002 Dec; 8(6):369-78. PubMed ID: 12528088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.